Emergent BioSolutions Inc. — Director's Dealing 2020

May 6, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2020-05-05

Reporting Person: Richard Ronald (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-05-05	Common Stock	S	8375	$80.1945	Disposed	8020	Direct

Footnotes

F1: Consists of restricted stock units granted under the Company's Stock Incentive Plan, as amended and restated.

F2: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.0000 to $80.8660, inclusive.